定义生物学和临床可信性:DICSA框架对跨治疗领域的生存推断进行协议化评估
PharmacoEconomics
|March 29, 2025
概括
本研究定义并提供了一个框架,用于评估生存推断的生物/临床合理性,提高卫生技术评估的透明度. 它确保生存预测与先验预期对准,以获得可靠的终身增量生存估计.
科学领域:
- 医疗技术评估 (HTA) 是指对医疗技术进行评估.
- 生存分析的分析.
- 药物经济学 药物经济学
背景情况:
- 卫生技术评估的指导文件经常强调生命存活率推断的生物/临床合理性,没有明确的定义.
- 缺乏标准化的定义,阻碍了在HTA中对可信性评估的一致应用.
研究的目的:
- 定义生物学和临床上可信的终身生存推断.
- 提出一个系统的框架,通过比较预先建模的生存预期与最终建模的推断来评估可信性.
- 为统一的基于证据的评估,将这个框架嵌入到一个生存推断协议模板中.
主要方法:
- 针对29份来自关键HTA机构 (如NICE,PBAC,HAS) 的指导文件进行了有针对性的审查.
- 专注于生存分析方法,证据综合,成本效益建模和观察数据的使用.
- 开发了一种五步方法 (DICSA) 来实现可信性评估.
主要成果:
- 从生物学/临床上可信的生存推断是那些预测的生存率处于先验可信的范围内,从合理的方法学中得出的推断.
- 先验预期必须整合所有可用的证据,并考虑当地环境 (患者群体,治疗途径,国家).
- DICSA方法通过描述,信息收集,比较,预期设置和对齐评估来操作预先编制的可信性评估.
结论:
- 拟议的定义和评估生存推断可信性的框架提高了透明度.
- 生存推算协议模板有助于制定可靠和基于证据的终身生存估计.
- 标准化可信性评估有助于更强大的医疗技术评估.
相关概念视频
01:28Preclinical Development: Overview
4.3K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.3K
01:11Clinical Trials: Overview
2.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.9K
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
124
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
124
01:15Assumptions of Survival Analysis
111
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
111
01:20Comparing the Survival Analysis of Two or More Groups
164
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
164
01:21Cancer Survival Analysis
334
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
334